TOFACITINIB vs TOFACITINIB WITH MESALAMINE IN ULCERATIVE COLITIS
NCT06625450
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Tofacitinib
DRUG:
Tofacitinib plus mesalamine
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh